Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger

Bruce Y. Lee*, Tina Marie Assi, Jayant Rajgopal, Bryan A. Norman, Sheng-I Chen, Shawn T. Brown, Rachel B. Slayton, Souleymane Kone, Hailu Kenea, Joel S. Welling, Diana L. Connor, Angela R. Wateska, Anirban Jana, Ann E. Wiringa, Willem G. Van Panhuis, Donald S. Burke

*此作品的通信作者

研究成果: Article同行評審

32 引文 斯高帕斯(Scopus)

摘要

Objectives. We investigated whether introducing the rotavirus and pneumococcal vaccines, which are greatly needed in West Africa, would overwhelm existing supply chains (i.e., the series of steps required to get a vaccine from the manufacturers to the target population) in Niger. Methods. As part of the Bill and Melinda Gates Foundation-funded Vaccine Modeling Initiative, we developed a computational model to determine the impact of introducing these new vaccines to Niger's Expanded Program on Immunization vaccine supply chain. Results. Introducing either the rotavirus vaccine or the 7-valent pneumococcal conjugate vaccine could overwhelm available storage and transport refrigerator space, creating bottlenecks that would prevent the flow of vaccines down to the clinics. As a result, the availability of all World Health Organization Expanded Program on Immunization vaccines to patients might decrease from an average of 69% to 28.2% (range=10%-51%). Addition of refrigerator and transport capacity could alleviate this bottleneck. Conclusions. Our results suggest that the effects on the vaccine supply chain should be considered when introducing a new vaccine and that computational models can help assess evolving needs and prevent problems with vaccine delivery.

原文English
頁(從 - 到)269-276
頁數8
期刊American Journal of Public Health
102
發行號2
DOIs
出版狀態Published - 1 二月 2012

指紋

深入研究「Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger」主題。共同形成了獨特的指紋。

引用此